Canada: from 50% duty to targeted import ban.
The practical question is no longer only “what is the duty rate?” For specified covered merchandise, admissibility itself can be the issue.
Is the exact HTS in scope?
Start with the annex and product-specific scope limitation. Category labels are not enough.
When was the merchandise imported?
Pre-cutoff inventory can require a different treatment analysis from merchandise arriving on or after the effective time.
Will ACE accept the filing?
CBP identified reject behavior and restrictions affecting entry, FTZ, bonded warehouse and in-bond pathways for covered merchandise.
A tariff changes the cost of entry. A prohibition can change whether entry is available at all. That makes the classification-and-scope review a threshold admissibility question rather than only a landed-cost exercise.
- Confirm the HTSUS line.
- Read the annex and scope limitation.
- Confirm the relevant import or withdrawal timing.
- Check current ACE and CBP filing instructions.
100% can be the starting point — not always the final rate.
Pharma Section 232 is an example of why a headline rate cannot replace product-by-product entry analysis.
CBP describes heading 9903.04.60 as a 100% combined column-one and Section 232 duty rate for covered patented pharmaceutical articles.
Potential treatment depends on the applicable country/product/company facts, specialty-use provisions, generics, U.S.-origin status and other instructions.
The newsletter’s CBP guidance notes that preferential treatment does not automatically remove Section 232 exposure. The entry review therefore has to separate ordinary tariff preference from the additional trade-remedy framework.
Good news. Now show us the implementation.
The recommended lists matter, but customs operations still need an effective legal mechanism and filing instructions.
Product recommendations + framework.
Recommended product lists cover roughly $30 billion of non-sensitive trade on each side.
Entry-level implementation.
Effective date, HTS/Chapter 99 mapping, goods in transit, FTZ treatment, stacking, exclusions, drawback and CBP/Federal Register implementation.
The trade rule is increasingly about evidence — and liquidation.
Recent developments connect supply-chain facts and labor enforcement directly to customs outcomes.
Import bans are going global.
USTR convened more than 50 trading partners for training on imposing and enforcing forced-labor import prohibitions.
Yokohama: liquidation suspended.
A facility-level labor review translated into an operational customs consequence for goods from the facility.
Akwel Juárez: liquidation resumes.
Remediation produced the reverse path: Treasury was directed to resume liquidation of unliquidated entries.
Diesel export ban? Not yet.
This item belongs in the watchlist, not in the “current customs rule” column.
The first October watchlist.
The first week is about seeing how newly effective measures behave under real filing conditions.
ACE rejects, scope questions and treatment of pre-Sept. 29 inventory.
Chapter 99 selection, company-specific rates, specialty use, FTZ and drawback questions.
Any implementing notice, effective date or CBP filing instruction for the 30-for-30 framework.
Operational status of Yokohama liquidation suspension and any additional facility-level actions.
Official White House / DOE action, if any, rather than market speculation.
Can your team answer these before the next entry?
Use this as a conversation starter, not a legal conclusion or CBP score.
Turn the next entry into a defensible operating file.
If one or more answers are “not yet,” TradeFlex can help review product scope, classification, Chapter 99 treatment, origin, FTZ/drawback considerations and the supporting file.